SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000892712-20-000074
Filing Date
2020-02-11
Accepted
2020-02-11 15:52:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G djmsc13ga.htm SC 13G/A 29642
  Complete submission text file 0000892712-20-000074.txt   30971
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Subject) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88808 | Film No.: 20596360
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2146 SWANSTONE CIRCLE DE PERE WI 54115
Business Address
Mangless Daniel John (Filed by) CIK: 0001779475 (see all company filings)

Type: SC 13G/A